Gilead Sciences files $1.65B Form 13F holdings
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Gilead Sciences, Inc. filed a quarterly institutional holdings report as an institutional investment manager. The report is a Form 13F Holdings Report, indicating that all reportable holdings for this manager are included. The filing covers 5 reportable positions with an aggregate reported value of $1,648,747,919, rounded to the nearest dollar. One additional manager, Gilead Therapeutics A1 Unlimited Co, is listed as an other included manager in the filing.
Key Figures
Key Terms
Form 13F regulatory
Institutional Investment Manager regulatory
13F HOLDINGS REPORT regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Gilead Sciences (GILD) file in this Form 13F?
How many positions and what total value are reported by Gilead Sciences (GILD)?
Is this Gilead Sciences (GILD) Form 13F a full holdings report or a notice?
Which other manager is included in Gilead Sciences (GILD) Form 13F?
Who signed the Gilead Sciences (GILD) Form 13F and in what capacity?
AI-generated analysis. How Rhea-AI works. Not financial advice.